Total planned funding: $110,751,220
Allocations
Countries/Regions
Ukraine | $110,751,220 |
Organizational Types
Private Contractor | $28,578,578 |
Unknown | $25,793,032 |
NGO | $20,937,998 |
Own Agency | $12,341,932 |
Multi-lateral Agency | $10,288,586 |
Other USG Agency | $4,589,094 |
University | $4,150,000 |
Implementing Agency | $4,072,000 |
Program Areas
Governance and Systems | $46,239,900 |
Treatment | $22,102,678 |
Prevention | $14,301,405 |
Testing | $10,222,381 |
Management and Operations | $8,761,510 |
Care | $8,710,646 |
Budget Codes
OHSS: Health Systems Strengthening | $24,403,035 |
HVSI: Strategic Information | $12,091,601 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HTXS: Treatment: Adult Treatment | $10,697,388 |
HVCT: Testing: HIV Testing and Counseling | $10,222,381 |
HLAB: Laboratory Infrastructure | $9,745,264 |
HVMS: Management and Operations | $8,761,510 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,947,216 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,713,400 |
HVTB: Care: TB/HIV | $5,250,861 |
HMBL: Biomedical Prevention: Blood Safety | $2,142,932 |
HKID: Care: Orphans and Vulnerable Children | $1,873,444 |
HBHC: Care: Adult Care and Support | $1,586,341 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $204,500 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$26,497,748
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$10,992,932
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions